Clients in the media Clients IN the MEDIA

Ensuring your story is visible.

Biotech around the World: The West Coast of the United States

Capricor Therapeutics, for instance, is developing cell and exosome-based technologies to treat or prevent a broad range of diseases.

Antimicrobial resistance with Recce Pharmaceuticals

Recce Pharmaceuticals is at the forefront of developing a new class of synthetic anti-infectives with a unique mechanism of action.


Breaking the Stigma with Advancements in Psychedelics

In this episode of Breakthrough Economy, MindMed CEO Robert Barrow chats with Host Jen Rogers about how his company, which was the first psychedelic pharmaceutical company to go public, is working to unlock the full therapeutic potential of psychedelics and other novel therapeutic targets.


Women in Science: Cynthia Pussinen, CEO of Sernova on how her career was ‘written in the stars’

Cynthia Pussinen knew she wanted to work in STEM fields by the time she was a teenager, she received a full scholarship to study nuclear engineering but after two years changed to chemistry for her major.

Everybody Has a Thyroid… What Could Go Wrong??? Dr. Mark Sumeray, CMO of Amolyt Pharma

Dr. Mark Sumeray from Amolyt Pharma talks about their innovative approach to treating hormonal conditions. We’ll talk about two – when your parathyroid has been injured or removed, often during thyroid surgery, and another – when the pituitary starts overproducing growth hormone.

Overviewing Preliminary Data of ABvac40, a Vaccine for Alzheimer Disease: Jose Terencio

The vice president of Innovation and New Technologies at Grifols provided perspective on the interim phase 2 findings of ABvac40, a vaccine in development for patients with Alzheimer disease.

Navigating the challenges of cell therapies

Vittoria’s innovative Senza5 platform, with its unique CD5-targeting approach, aims to enhance the efficacy, safety, and speed of cell therapies.


The Legend Steve Gorlin’s Golden Rules

This week, the Business of Biotech sits down with the legendary biotech investor Steve Gorlin, now CEO of CoRegen, for a conversation on his golden rules for picking winners.